301507.SZ
Hangzhou Minsheng Healthcare Co., Ltd.
SZSE · C 制造业 · CN
CNY 12.66
−1.71%Aug 6, 2026, 09:05 UTC
Minsheng Health and its subsidiaries recently received three invention patent certificates from the China National Intellectual Property Administration, covering a resveratrol choline solid dispersion, Limosilactobacillus reuteri, and Lactobacillus rhamnosus JYLR-219, but they have not yet been applied to products and will not have a significant impact on production and operations.
Source:Aug 5, 2026, 09:34 UTC
Minsheng Health repurchased 2.32 million shares for 34.1525 million yuan as of July 31, 2026, as part of its second buyback plan.
Source: